All News Kelyniam Global, Inc.

Equities

KLYG

US4883591004

Market Closed - OTC Markets Other stock markets 02:58:49 2024-05-16 pm EDT			5-day change	1st Jan Change
0.0673 ^USD	+3.54%		+56.15%	+9.43%

Apr. 02	Kelyniam Global Announces NEOS Surgery Cranial LOOP? Fixation System Receives 510(k) Clearance from the FDA for use with Finceramica's CustomizedBone? Hydroxyapatite Cranial Implant	CI
Mar. 17	Kelyniam Global, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kelyniam Global Releases Q1 Financials	May. 13	PR
NEOS Cranial LOOP™ Receives FDA Clearance for CustomizedBone™ Use	Apr. 02	PR
Kelyniam Global Announces NEOS Surgery Cranial LOOP? Fixation System Receives 510(k) Clearance from the FDA for use with Finceramica's CustomizedBone? Hydroxyapatite Cranial Implant	Apr. 02	CI
Strong Fourth Quarter Powers 2023 Kelyniam Financials	Mar. 17	PR
Kelyniam Global, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 16	CI
Kelyniam Global Releases 3rd Quarter 2023 Financials	Dec. 21	PR
Kelyniam Global, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	Dec. 10	CI
Kelyniam Global Releases 2nd Quarter 2023 Financials	23-08-14	PR
Kelyniam Global Releases Q1 Financials, Announces Licensing Agreement with Bioplate for Osteopore Products	23-05-22	PR
Kelyniam Global, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-17	CI
Kelyniam Global, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-19	CI
Kelyniam Global Announces Record Sales of $3 million in 2022 Financial Statements	23-03-16	PR
Kelyniam Global Announces 3rd Quarter Results	22-11-15	PR
Kelyniam Global, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-11-13	CI
Singular Health Group Ltd Appoints Kelyniam Global, Inc. and CG1 Solutions as Agents	22-11-08	CI
Kelyniam Global Announces 1st Half Results Outstanding Quarter and Sales Momentum into the Second Half	22-08-15	PR
Kelyniam Global, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-07	CI
Kelyniam Announces New Vice President of Sales and Strategic Development	22-07-11	PR
Kelyniam Global Announces 1st Quarter Results	22-05-08	PR
Kelyniam Global, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Kelyniam Global, Inc.

Equities

KLYG

US4883591004

All News

Filters